NEW YORK (GenomeWeb News) – German molecular diagnostics firm Curetis today announced that it has inked new distribution partnerships for its Unyvero system, a PCR-based technology for isolation and detection of bacteria and antibiotic resistance, in Italy and the Middle East.
According to the company, it will now distribute the system in Italy through Arrow Diagnostics, and in Qatar and the United Arab Emirates through Al Zahrawi Medical.
Meanwhile, Curetis said that it has also expanded its direct sales and marketing force in Europe and the Middle East. Specifically, the firm has appointed Klaudija Kiesinger as its new head of international sales for Western Europe and plans to add four new members to its international sales and marketing team by mid-year, which would bring the total number of commercial reps to 14.
The move, Curetis said, adds the UK, France, Belgium, the Netherlands, and Luxembourg to its direct sales markets. It will also "accelerate time to market, give us more direct customer access, and provide more control over platform placements," Curetis CEO Oliver Schacht said in a statement.